Oct 31, 2011 12:41 PM by Matt Stafford

FDA backs Vytorin for kidney disease patients

WASHINGTON (AP) - The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.

The agency's review also found no new safety concerns with Vytorin, which came under scrutiny for potential cancer risks in 2009.

Merck & Co. has asked the FDA to approve the drug for a new use in reducing heart-related problems chronic kidney disease patients. The combination pill is already cleared to reduce bad cholesterol.

FDA says that Vytorin lowered kidney disease patients' heart-related problems by 16 percent compared with placebo.

On Wednesday, a panel of non-government FDA advisers will vote on the new use.

Vytorin, a multibillion-dollar drug for Merck, combines two brand-name cholesterol pills Zocor and Zetia.


»Topics in this article

More News

Weather - Forecast
Story Photo

11 hours ago

Cooler Thursday

Windy early with blowing dust in some areas. Wind ending overnight tonight. An isolated thunderstorm possible early. Overnight low temperatures will drop...

Most Popular

Top Videos

1 2 3 4